Lyra Therapeutics Inc

Research Lyra Therapeutics Inc (LYRA) on Bullrun: market cap USD 1.12M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerLYRA
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 1.12M
• Financial periodFY2025
• RevenueUSD 398.00K
• Revenue growth-74.1%
• Net income-USD 28.92M
• Free cash flow-USD 28.98M

Valuation Snapshot

latest market cap is USD 1.12M.

About Lyra Therapeutics Inc

Lyra Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development and commercialization of anti-inflammatory therapies for the treatment of patients with chronic rhinosinusitis. Its technology is designed to deliver medicines directly to the affected tissue for sustained periods with a single administration. The company's product candidates include LYR-210, an anti-inflammatory implantable drug matrix which is in Phase III clinical trial for the treatment of chronic rhinosinusitis (CRS);

Frequently asked questions

What is Lyra Therapeutics Inc's market cap?

Lyra Therapeutics Inc's market capitalization is USD 1.12M.

What does Lyra Therapeutics Inc do?

Lyra Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development and commercialization of anti-inflammatory therapies for the treatment of patients with chronic rhinosinusitis.